Definitive Contract 75F40120C00098

Award Date 8/5/20
Potential Completion Date 5/16/22
Potential Value $4M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,456,062.35 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for support to conduct 10 post-market safety studies, with a period of performance through August 29, 2025. ICA has an extensive track record of delivering a wide range of healthcare IT, data analytics, and management consulting services to federal...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed-price definitive contract to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business, to provide a natural language querying module for the Center for Devices and Radiological Health (CDRH). The $3,703,521.60 contract was awarded on September 14, 2022, with a completion date of March 19, 2024. ICA has extensive experience...
This is a $3,940,013.28 Definitive Contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for post-market safety studies and has a completion date of March 20, 2022. It is an 8(a) sole source award. ICA is a specialized healthcare IT and management consulting firm that has an extensive track record of supporting federal health agencies like the FDA and...
This $3,976,584.00 firm fixed price federal contract was awarded to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a) minority-owned small disadvantaged business, by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS). The 2-year contract, titled "CDRH REAL-WORLD DATA ANALYSES," is for ICA to provide advanced data analytics, artificial intelligence, healthcare IT, and management consulting services...
This federal contract award for $3,885,609.18 was issued by the Food and Drug Administration (FDA), a civilian agency under the Department of Health and Human Services (HHS), to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for literature analysis services to support the Center for Devices and Radiological Health (CDRH) within the FDA. This is a definitive, firm fixed-price contract with a completion date...
This federal contract award, with an ID of 75F40124A00021|75F40124F19001, was issued by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a) minority-owned small disadvantaged business. The contract, valued at $55,857,159.92, is a Blanket Purchase Agreement (BPA) Call task order for the Center for Devices and Radiological Health (CDRH) and does not have a set-aside designation. ICA will provide a range of services to the FDA,...
The U.S. Food and Drug Administration (FDA) has awarded a $4,077,696.00 Firm Fixed Price, Definitive Contract to International Consulting Associates, Inc. (ICA) to develop AI-enabled user workflows and dashboards for the Center for Devices and Radiological Health (CDRH). This 8(a) sole source contract, running through September 2024, is part of the FDA's broader "ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS" initiative. ICA, an...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to International Consulting Associates Inc. (ICA), an SBA-certified 8(a) small business. The $202,946.14 contract is for research to evaluate how the FDA's Center for Devices and Radiological Health (CDRH) assesses real-world evidence in regulatory submissions and identify best practices. ICA, a minority-owned small business, specializes in healthcare data...
This contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The $4,224,342.40 Firm Fixed Price Definitive Contract is for CDRH MDE AI PRESCRIPTIVE ANALYTICS services, with an ultimate completion date of September 24, 2024. The contract was awarded as an 8(a) Sole Source. ICA is a specialized provider of advanced data analytics, artificial...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to International Consulting Associates Inc. (ICA), an SBA-certified 8(a) small business. The contract is for $174,286.95 and provides consulting services to support research into the FDA's use of computerized maintenance management system analytics and three-way invoice matching. The contract has a completion date of July 29, 2020 and was awarded on September 23,...

The Department of Health and Human Services' Food and Drug Administration awarded International Consulting Associates Inc., doing business as ICA, a $4 million firm fixed price contract to provide premarket data services. To be performed in Silver Spring, Maryland over a 21-month period ending in May 2022, this contract was set aside for small businesses under the 8(a) Program. ICA will deliver premarket data and regulatory support to the FDA as it reviews new drugs, medical devices, and other products prior to their availability to consumers. No major subcontractors were identified. This award furthers the FDA's mission to protect public health by ensuring the safety and effectiveness of medical products nationwide.

Generated 12/25/23, 5:48 AM